NAVAMEDIC AS

Org. no. 920969836 · OSLO · Founded 2018

Score · fiscal year 2025

65of 100

How to read this: the company is ahead of 78 % of companies in the Morning class Medium in the same sector in 2025. What does this mean?

Rank in the Morning class Medium: 813 of 3,712 · What are Morning company classes?
Place in the whole sector: 4,987 of 23,065 · Handel

Profile

Lion · Leader

High profitability, high solidity

Position against comparable companies in 2025, not a verdict on the company. Based on profitability 90 and solidity 89 out of 100 among companies in the Morning class Medium in the same sector in 2025. Methodology

Against the sector

NAVAMEDIC AS is 15 points above the median for companies in the Morning class Medium in the same sector in 2025.

Median score 50 among 3,712 companies.

Against companies in the Morning class Medium in the same sector in 2025: operating margin 19.7% (median 3.0%) and equity ratio 65.3% (median 30.0%).

Source: Register of Company Accounts and Central Coordinating RegisterFetched 26 October 2026Report an issue
Key figures · 2025

The numbers behind the score

The numbers behind the score · 2025
MeasureCompanyMedianAhead of
Operating revenue202 MNOK93 MNOK
Operating margin 19.7% 3.0% 97 %
Profit margin 22.1% 2.8% shown, not part of the index
Return on assets 25.4% 11.6% 83 %
Equity ratio 65.3% 30.0% 90 %
Debt-to-equity 0.53 2.24 89 %
Current ratio 1.10 1.39 22 %
Revenue growth 0.1% 6.1% 27 %

The median and “ahead of” refer to companies in the Morning class Medium in the same sector in 2025. The bar shows the share of companies the figure is ahead of.

With an index of 65, NAVAMEDIC AS does better than 78% of companies in the Morning class Medium in the same sector (3,712 companies) in 2025.

Over time

Score 2023–2025

CompanyMedian0255075100202320242025
  • NAVAMEDIC AS
  • Median: companies in the Morning class Medium in the same sector
Summary analysis

NAVAMEDIC AS has a score of 65 for 2025, rank 4,987 of 23,065 in the sector.

Strongest: Profitability: percentile 90 against peers, operating margin 19.7% against a median of 3.0%. Solidity: percentile 89 against peers, equity ratio 65.3% against a median of 30.0%.

Weakest: Liquidity: percentile 22 against peers, current ratio 1.10 against a median of 1.39. Growth: percentile 27 against peers, revenue growth 0.1% against a median of 6.1%.

Worth a closer look

Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made

Analysis · 2025

What the numbers say

NAVAMEDIC AS had an operating margin of 19.7% and an equity ratio of 65.3% in 2025, and ranks 4,987 of 23,065 in Handel.

From 2024 to 2025: the equity ratio fell from 73.4% to 65.3%.

This text is generated automatically from the 2025 accounts.

Estimated value · 2025

Three simple methods

The methods give between 145 MNOK and 357 MNOK.

MethodInputMultipleEstimate
P/E Net profit: 34.7 MNOK 10.0 347 MNOK
EV/EBIT Operating profit: 39.8 MNOK
minus net debt −39.3 MNOK
8.0 357 MNOK
P/B Equity: 144.8 MNOK 1.0 145 MNOK

A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation

Indications · 2025

Worth a closer look

No rules were triggered for this year.

Indications based on the latest annual accounts from open data. Not investment or financial advice.

Financial costs were 15.2% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.

Data quality

No anomalies found in the figures.

Stress test · 2022

Scenario analysis: the sector's weakest year

We have no accounts for 2022, the sector's weakest year, for this company.

The sector's weakest year was 2022, with a median operating margin of 1.5%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology

Components · 2025

What the score is made of

Profitability90 weight 30%
Solidity89 weight 25%
Liquidity22 weight 15%
Growth27 weight 15%
Consistency54 weight 15%

Durability: 72 (average over 3 years)

Index version 2. Data completeness 100%: the share of the weights that had data.

2025

Questions and answers

How profitable is NAVAMEDIC AS?

The operating margin was 19.7% in 2025, against a median of 3.0% among companies in the Morning class Medium in the same sector. Return on assets was 25.4%.

How solid is NAVAMEDIC AS?

The equity ratio was 65.3% in 2025 (median 30.0%). Debt-to-equity was 0.53 (median 2.24).

What is the liquidity of NAVAMEDIC AS like?

The current ratio was 1.10 in 2025 (median 1.39).

How does NAVAMEDIC AS compare in Handel?

NAVAMEDIC AS ranks 4,987 of 23,065 in Handel for 2025. Among companies in the Morning class Medium it is number 813 of 3,712. Revenue changed by 0.1% from the year before.

Group accounts

The company is registered as part of a group, but we have no group accounts for it. Group accounts are filed by the parent company, and open data does not say which company that is.

Read the figures with care: a company in a group can look strong because of group contributions, or weak because dividends go up to the parent. The figures are indications, not the full picture.

We do not show the group structure, because open data does not say who owns whom.

From the Central Coordinating Register

Org. no.
920969836
Legal form
AS · part of a group
Sector
Handel (46.460)
Morning company class
Medium
Employees
0–4 (not registered)
Founded
18 May 2018 8 years in operation
Share capital
1.48 MNOK
Business address
c/o Navamedic ASA, Henrik Ibsens gate 100, 0255 OSLO
Municipality
Oslo rank 63–221 of 357 in Norway
Latest accounts filed
2025

Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre

Ownership and roles

Chair of the board
Lars Enghave Minor
Board member
Nils Ole Krekling
Auditor
ERNST & YOUNG AS
Accountant
SOLIDITET AS

Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.

Owners and shareholdings will appear here once the shareholder data extract is in place.

Coming · not built yet

Error in the data?

Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.

Report an issue

Figures last fetched 26 October 2026.

Details

Year by year · 2023–2025

Key figure202320242025Trend
Index777565
Rank2,6401,9014,987
Operating margin23.4%20.4%19.7%
Return on assets25.1%29.8%25.4%
Equity ratio57.2%73.4%65.3%
Current ratio2.331.841.10
Revenue growth–−6.5%0.1%

Accounts

From the Brønnøysund Register Centre, in the company's reporting currency (NOK).

Key figure202320242025
Operating revenue215.6 MNOK201.6 MNOK201.8 MNOK
Operating profit50.4 MNOK41.2 MNOK39.8 MNOK
Profit before tax54.1 MNOK49.3 MNOK44.5 MNOK
Net profit42.2 MNOK38.5 MNOK34.7 MNOK
Financial expenses4.7 MNOK9.4 MNOK11.7 MNOK
Total assets234.4 MNOK197.1 MNOK221.6 MNOK
Current assets234.4 MNOK96.5 MNOK84.3 MNOK
Equity134.0 MNOK144.8 MNOK144.8 MNOK
Retained earnings25.4 MNOK36.1 MNOK36.1 MNOK
Total liabilities100.4 MNOK52.3 MNOK76.9 MNOK
Current liabilities100.4 MNOK52.3 MNOK76.9 MNOK

Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 26 October 2026, accounts id 7087611.